After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Earlier, Yahoo Finance discussed this stock as it revealed Cronos Group Inc. to Hold 2023 Fourth Quarter and Full-Year Earnings Conference Call on February 29, 2024.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Cronos Group Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Drug Manufacturers – Specialty & Generic industry. At the end of the last regular session, the stock closed at $2.26 and fluctuated between $2.3200 as its day high and $2.2500 as its day low. The current market capitalization of Cronos Group Inc is $861.31M. A total of 1.66 million shares were traded on the day, compared to an average of 2.14M shares.
Insider Activity
Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, CRON has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 54 BUYs and 31 SELLs from insiders. Insiders purchased 3,454,451 shares during that period but sold 228,394.
In the most recent transaction, ADLER JASON MARC bought 37,500 shares of CRON for 1.74 per share on May 30. After the transaction, the Director now owns 1,402,304 company shares. In a previous transaction on May 25, ADLER JASON MARC bought 100,000 shares at 1.80 per share. CRON shares that Director owns now total 1,376,054.
Among the insiders who bought shares, ADLER JASON MARC acquired of 100,000 shares on May 23 at a per-share price of $1.90. This resulted in the Director holding 1,306,055 shares of CRON after the transaction. In another insider transaction, ADLER JASON MARC bought 100,000 shares at $1.89 per share on May 19. Company shares held by the Director now total 1,236,056.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for CRON in the last 3 months, the mean price target is $2.63 with high estimates of $3.62 and low estimates of $1.98. In terms of 52-week highs and lows, CRON has a high of $2.64 and a low of $1.64.
As of this writing, CRON has an earnings estimate of -$0.01 per share for the current quarter. EPS was calculated based on a consensus of 2 estimates, with a high estimate of -$0.01 per share and a lower estimate of -$0.02. The company reported an EPS of -$0.01 in the last quarter, which was 66.70% higher than expectations of -$0.03.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. CRON’s latest balance sheet shows that the firm has $1.00B in Cash & Short Term Investments as of fiscal 2021. There were $9.81M in debt and $54.37M in liabilities at the time. Its Book Value Per Share was $2.94, while its Total Shareholder’s Equity was $1.33B.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CRON is Buy with a score of 3.63.
